These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26530415)

  • 41. Maximum likelihood estimation of the attributable fraction from logistic models.
    Greenland S; Drescher K
    Biometrics; 1993 Sep; 49(3):865-72. PubMed ID: 8241375
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nonparametric estimation of time-dependent ROC curves conditional on a continuous covariate.
    Rodríguez-Álvarez MX; Meira-Machado L; Abu-Assi E; Raposeiras-Roubín S
    Stat Med; 2016 Mar; 35(7):1090-102. PubMed ID: 26487068
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Simultaneous inference for longitudinal data with detection limits and covariates measured with errors, with application to AIDS studies.
    Wu L
    Stat Med; 2004 Jun; 23(11):1715-31. PubMed ID: 15160404
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A simulation system for biomarker evolution in neurodegenerative disease.
    Young AL; Oxtoby NP; Ourselin S; Schott JM; Alexander DC;
    Med Image Anal; 2015 Dec; 26(1):47-56. PubMed ID: 26356148
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Likelihood-based inferences about the mean area under a longitudinal curve in the presence of observations subject to limits of detection.
    Chandrasekhar R; Shi Y; Hutson AD; Wilding GE
    Pharm Stat; 2015; 14(3):252-61. PubMed ID: 25832442
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hybrid pooled-unpooled design for cost-efficient measurement of biomarkers.
    Schisterman EF; Vexler A; Mumford SL; Perkins NJ
    Stat Med; 2010 Feb; 29(5):597-613. PubMed ID: 20049693
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A simulation-based marginal method for longitudinal data with dropout and mismeasured covariates.
    Yi GY
    Biostatistics; 2008 Jul; 9(3):501-12. PubMed ID: 18199691
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tests for detecting overdispersion in models with measurement error in covariates.
    Yang Y; Wong MY
    Stat Med; 2015 Nov; 34(27):3563-76. PubMed ID: 26119624
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia.
    Ramírez P; Ferrer M; Martí V; Reyes S; Martínez R; Menéndez R; Ewig S; Torres A
    Crit Care Med; 2011 Oct; 39(10):2211-7. PubMed ID: 21705887
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis.
    Angus DC; Yang L; Kong L; Kellum JA; Delude RL; Tracey KJ; Weissfeld L;
    Crit Care Med; 2007 Apr; 35(4):1061-7. PubMed ID: 17334246
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High-mobility group box 1 (HMGB1) as a potential therapeutic target in sepsis--more questions than answers.
    Waterer GW
    Crit Care Med; 2007 Apr; 35(4):1205-6. PubMed ID: 17413792
    [No Abstract]   [Full Text] [Related]  

  • 52. A maximum likelihood method for secondary analysis of nested case-control data.
    Salim A; Xiangmei M; Jialiang L; Reilly M
    Stat Med; 2014 May; 33(11):1842-52. PubMed ID: 24753004
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biomarkers of Host Response Predict Primary End-Point Radiological Pneumonia in Tanzanian Children with Clinical Pneumonia: A Prospective Cohort Study.
    Erdman LK; D'Acremont V; Hayford K; Rajwans N; Kilowoko M; Kyungu E; Hongoa P; Alamo L; Streiner DL; Genton B; Kain KC
    PLoS One; 2015; 10(9):e0137592. PubMed ID: 26366571
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia.
    España PP; Capelastegui A; Mar C; Bilbao A; Quintana JM; Diez R; Esteban C; Bereciartua E; Unanue U; Uranga A
    J Infect; 2015 May; 70(5):457-66. PubMed ID: 25499199
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mixed-effects models for censored data with autoregressive errors.
    Olivari RC; Garay AM; Lachos VH; Matos LA
    J Biopharm Stat; 2021 May; 31(3):273-294. PubMed ID: 33315523
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Positing, fitting, and selecting regression models for pooled biomarker data.
    Mitchell EM; Lyles RH; Schisterman EF
    Stat Med; 2015 Jul; 34(17):2544-58. PubMed ID: 25846980
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Joint models for longitudinal and time-to-event data in a case-cohort design.
    Baart SJ; Boersma E; Rizopoulos D
    Stat Med; 2019 May; 38(12):2269-2281. PubMed ID: 30706536
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Case-cohort analysis with accelerated failure time model.
    Kong L; Cai J
    Biometrics; 2009 Mar; 65(1):135-42. PubMed ID: 18537948
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A heteroscedastic measurement error model for method comparison data with replicate measurements.
    Nawarathna LS; Choudhary PK
    Stat Med; 2015 Mar; 34(7):1242-58. PubMed ID: 25614299
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Penalized likelihood approach to estimate a smooth mean curve on longitudinal data.
    Jacqmin-Gadda H; Joly P; Commenges D; Binquet C; Chêne G
    Stat Med; 2002 Aug; 21(16):2391-402. PubMed ID: 12210623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.